Pharma Under The Gun: FDA And DoJ Use Tough Tactics In Investigations
Executive Summary
Former government attorneys offer advice on how companies can respond to government search warrants and fake identities; current prosecutors discuss the tools they use and the kinds of cases they are pursuing.
You may also be interested in...
FDA’s New Criminal Investigations Chief Wants Global Reach
Office of Criminal Investigations Director George Karavetsos talks about the Park Doctrine and off-label enforcement in an interview.
FDA’s New Criminal Investigations Chief Wants Global Reach
Office of Criminal Investigations Director George Karavetsos talks about the Park Doctrine and off-label enforcement in interview with “The Pink Sheet.”
FDA Investigators Search For Silver Bullets In Off-Label Probes
OCI Director John Roth set to depart upon his confirmation to Homeland Security Department post.